Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
July 08, 2024 08:20 ET
|
Microbot Medical Inc.
The first clinical case was performed at Brigham and Women’s Hospital The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY® Endovascular...
Bank of Southern California Announces the Hiring of Three Seasoned Commercial Lenders
July 08, 2024 08:15 ET
|
Southern California Bancorp
San Diego, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- Bank of Southern California, N.A. (“us,” “we,” “our,” or the “Bank”), the wholly owned subsidiary of Southern California Bancorp (Nasdaq: BCAL),...
Kandi's Off-Road Vehicles Will Begin Production in Taiwan
July 08, 2024 08:05 ET
|
Kandi Technologies Group, Inc.
JINHUA, CHINA, July 08, 2024 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) (“Kandi” or the “Company”), a leader in all-electric personal transportation and utility vehicles,...
Spectral AI Announces Collaboration with Global Wound Care Company PolyNovo to Introduce DeepView System for Burn Indication to Australian Market
July 08, 2024 08:00 ET
|
Spectral AI, Inc.
DALLAS, July 08, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
Allegro MicroSystems Redefines Magnetic Current Sensing with Compact, Integrated Solutions for Industrial, Automotive and Clean Energy Applications
July 08, 2024 08:00 ET
|
Allegro MicroSystems, Inc.
MANCHESTER, N.H., July 08, 2024 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing solutions for motion control and energy-efficient...
Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024
July 08, 2024 08:00 ET
|
Biora Therapeutics, Inc.
Event to highlight results from the clinical trial of BT-600, an orally administered drug-device combination in development for ulcerative colitis.
Merus Announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 2L CRC
July 08, 2024 08:00 ET
|
Merus N.V.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative,...
Belite Bio to Present at the JonesHealthcare Seaside Summit
July 08, 2024 08:00 ET
|
Belite Bio, Inc
SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting...
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia
July 08, 2024 08:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia Approximately 10 million adults in the U.S. are affected by fibromyalgia, predominantly...
NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib plus Ezetimibe in Patients with HeFH and/or ASCVD or ASCVD Risk Factors
July 08, 2024 08:00 ET
|
NewAmsterdam Pharma N.V.
NAARDEN, The Netherlands and MIAMI, July 08, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...